| 000 | 01900 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516212454.0 | ||
| 264 | 0 | _c20150205 | |
| 008 | 201502s 0 0 eng d | ||
| 022 | _a1532-866X | ||
| 024 | 7 |
_a10.1016/j.semarthrit.2013.10.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWitt, Matthias | |
| 245 | 0 | 0 |
_aDisease burden, disease manifestations and current treatment regimen of the SAPHO syndrome in Germany: results from a nationwide patient survey. _h[electronic resource] |
| 260 |
_bSeminars in arthritis and rheumatism _cJun 2014 |
||
| 300 |
_a745-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcquired Hyperostosis Syndrome _xdiagnosis |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aCost of Illness |
| 650 | 0 | 4 |
_aDelayed Diagnosis _xstatistics & numerical data |
| 650 | 0 | 4 |
_aDiphosphonates _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatient Satisfaction |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aMeier, Johanna | |
| 700 | 1 | _aHammitzsch, Ariane | |
| 700 | 1 | _aProft, Fabian | |
| 700 | 1 | _aSchulze-Koops, Hendrik | |
| 700 | 1 | _aGrunke, Mathias | |
| 773 | 0 |
_tSeminars in arthritis and rheumatism _gvol. 43 _gno. 6 _gp. 745-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.semarthrit.2013.10.010 _zAvailable from publisher's website |
| 999 |
_c23814297 _d23814297 |
||